Macrophage-mediated transfer of cancer-derived components to stromal cells contributes to establishment of a pro-tumor microenvironment

被引:0
|
作者
Michinobu Umakoshi
So Takahashi
Go Itoh
Sei Kuriyama
Yuto Sasaki
Kazuyoshi Yanagihara
Masakazu Yashiro
Daichi Maeda
Akiteru Goto
Masamitsu Tanaka
机构
[1] Akita University Graduate School of Medicine,Department of Molecular Medicine and Biochemistry
[2] Akita University Graduate School of Medicine,Department of Cellular and Organ Pathology
[3] Akita University Graduate School of Medicine,Department of Gastroenterology and Neurology
[4] Akita University,Department of Life Science, Faculty and Graduate School of Engineering and Resource Science
[5] National Cancer Center,Division of Pathology, Exploratory Oncology Research & Clinical Trial Center
[6] Osaka City University Graduate School of Medicine,Department of Surgical Oncology
[7] Osaka University,Department of Clinical Genomics, Graduate School of Medicine
来源
Oncogene | 2019年 / 38卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Tumor-derived extracellular vesicles (TEVs) secreted into the blood create a pre-metastatic niche in distant organs; however, it is unclear how TEVs are delivered and how they affect stromal cells in the tumor microenvironment. Tumor-associated macrophages (TAMs) have pivotal roles in cancer progression by interacting with cancer cells and other stromal cells. Here, we report a novel function of TAMs: delivery and transmission of TEV contents. TEV-incorporating macrophages (TEV-MΦs) showed increased invasiveness and were disseminated widely. Upon contact with host stromal cells (peritoneal mesothelial cells (PMCs), fibroblasts, and endothelial cells), TEV-MΦs released membrane blebs containing TEVs, a process dependent upon localized activation of caspase-3 in MΦs. Scattered blebs were incorporated into stromal cells, leading to transfer of cancer-derived RNA and proteins such as TGF-β, activated Src, Wnt3, and HIF1α. TEV-MΦ-secreted blebs containing cancer-derived components contributed to myofibroblastic changes in recipient stromal cells. TEVs delivered by MΦs penetrated deep into the parenchyma of the stomach in TEV-injected mice, and transmitted TEVs to PMCs lining the stomach surface; this process induced PMCs to undergo mesothelial–mesenchymal transition. PMCs infiltrated the gastric wall and created a niche, thereby promoting tumor invasion. Depletion of MΦs prevented these events. Moreover, TEV-MΦs created a pro-metastatic niche. Taken together, these results suggest a novel function for TAMs: transfer of cancer-derived components to surrounding stromal cells and induction of a pro-tumor microenvironment via an increase in the number of CAF-like cells.
引用
收藏
页码:2162 / 2176
页数:14
相关论文
共 41 条
  • [31] Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis
    Li, Mingyue
    Wang, Jiaying
    Wang, Conghui
    Xia, Lili
    Xu, Junfen
    Xie, Xing
    Lu, Weiguo
    EXPERIMENTAL CELL RESEARCH, 2020, 394 (01)
  • [32] Extracellular vesicle-mediated EBAG9 transfer from cancer cells to tumor microenvironment promotes immune escape and tumor progression
    Miyazaki, Toshiaki
    Ikeda, Kazuhiro
    Sato, Wataru
    Horie-Inoue, Kuniko
    Inoue, Satoshi
    ONCOGENESIS, 2018, 7
  • [33] Extracellular vesicle-mediated EBAG9 transfer from cancer cells to tumor microenvironment promotes immune escape and tumor progression
    Toshiaki Miyazaki
    Kazuhiro Ikeda
    Wataru Sato
    Kuniko Horie-Inoue
    Satoshi Inoue
    Oncogenesis, 7
  • [34] RETRACTED: Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression (Retracted Article)
    Wang, Jianhua
    Ying, Gigi
    Wang, Jingchen
    Jung, Younghun
    Lu, Jian
    Zhu, Jiang
    Pienta, Kenneth J.
    Taichman, Russell S.
    CANCER RESEARCH, 2010, 70 (02) : 471 - 480
  • [35] Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
    Peiming Zheng
    Lei Chen
    Xiangliang Yuan
    Qin Luo
    Yi Liu
    Guohua Xie
    Yanhui Ma
    Lisong Shen
    Journal of Experimental & Clinical Cancer Research, 36
  • [36] Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
    Zheng, Peiming
    Chen, Lei
    Yuan, Xiangliang
    Luo, Qin
    Liu, Yi
    Xie, Guohua
    Ma, Yanhui
    Shen, Lisong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [37] CD276 in tumor cells contributes to the M2 macrophage-rich immunosuppressive tumor microenvironment via upregulating the CCL2-CCR2 axis in ovarian cancer.
    Miyamoto, Taito
    Murakami, Ryusuke
    Ukita, Masayo
    Taki, Mana
    Yamanoi, Koji
    Abiko, Kaoru
    Yamaguchi, Ken
    Hamanishi, Junzo
    Kobayashi, Takashi
    Mandai, Masaki
    CANCER RESEARCH, 2021, 81 (13)
  • [38] Daratumumab Inhibits AML Metabolic Capacity and Tumor Growth through Inhibition of CD38 Mediated Mitochondrial Transfer from Bone Marrow Stromal Cells to Blasts in the Leukemic Microenvironment
    Mistry, Jayna J.
    Hellmich, Charlotte
    Moore, Jamie A.
    Marlein, Christopher R.
    Pillinger, Genevra
    Collins, Angela
    Bowles, Kristian M.
    Rushworth, Stuart A.
    BLOOD, 2019, 134
  • [39] RETRACTION: Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression (Retraction of Vol 70, Pg 471, 2010)
    Wang, Jianhua
    Ying, Gigi
    Wang, Jingchen
    Jung, Younghun
    Lu, Jian
    Zhu, Jiang
    Pienta, Kenneth J.
    Taichman, Russell S.
    CANCER RESEARCH, 2022, 82 (18) : 3405 - 3405
  • [40] CT-0508 is an Anti-HER2 Chimeric Antigen Receptor (CAR) Macrophage that Promotes a Pro-Inflammatory Solid Tumor Microenvironment and Eliminates Cancer Cells via Phagocytosis
    Klichinsky, Michael
    Gabrusiewicz, Konrad
    Anderson, Nicholas
    Lu, Xueqing
    Shestova, Olga
    Schmierer, Maggie
    Best, Andrew
    Ohtani, Yumi
    Chhum, Sotheavy
    Gill, Saar
    MOLECULAR THERAPY, 2020, 28 (04) : 15 - 15